Abstract
Continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD) are the predominant dialytic modalities for the majority of children while awaiting transplantation. Wide acceptability of peritoneal dialysis is hindered by infectious complications. A retrospective review of 367 pediatric patients treated with CAPD/CCPD for at least 3 months from September 1980 through December 1994 revealed that the peritonitis incidence ranged from 1.7 to 0.78 episodes per patient-year. No differences in peritonitis rates were observed between patients treated with CAPD or CCPD. Gram-positive organisms were responsible for the majority of peritonitis episodes. Age, sex, race, primary renal disease, presence of nephrotic syndrome, and serum albumin level were not associated risk factors. Longer time on treatment and diminished serum IgG level were associated with increased peritonitis incidence. Treatment was successfully completed at home in most cases. Almost half of the catheter losses were caused byStaphylococcus, Pseudomonas, and fungal peritonitis and tunnel/exit-site infections. Infectious complications are still the major causes of morbidity and treatment failure in patients treated with CAPD/CCPD. Thus, controlled studies are needed to assess methods for prevention or improvement of peritonitis rates in this patient population.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anonymous (1994) USRDS 1994 Annual Data Report (abstract). U.S. Renal Data System, Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases, pp 43–54
Alexander SR, Honda M (1993) Continuous peritoneal dialysis for children: a decade of worldwide growth and development. Kidney Int 43: S65-S74
Popovich RP, Moncrief JW, Decherd JF, Bomar JB, Pyle WK (1976) Definition of a novel portable/wearable equilibrium peritoneal dialysis technique (abstract). ASAIO Trans 5: 64
Nolph KD (1993) Update on peritoneal dialysis worldwide. Perit Dial Int 13: S-15–S-19
Levy M, Balfe JW, Geary DF, Fryer-Keene SP, Bannatyne RM (1988) Peritonitis in children undergoing dialysis. 10 years experience. Child Nephrol Urol 9: 253–258
Watson AR, Vigneux A, Bannatyne RM, Balfe JW (1986) Peritonitis during continuous ambulatory peritoneal dialysis in children. Can Med Assoc J 134: 1019–1022
Hogg RJ (1985) Continuous ambulatory and continuous cycling peritoneal dialysis in children. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27: 558–564
Lilien T von, Salusky IB, Boechat I, Ettenger RB, Fine RN (1987) Five years experience with continuous ambulatory/continuous cycling peritoneal dialysis in children. J Pediatr 111: 513–518
Fine RN, Salusky IB, Hall T, Lucullo L, Jordan S, Ettenger RB (1983) Peritonitis in children undergoing continuous ambulatory peritoneal dialysis. Pediatrics 71: 806–809
Verrina E, Bassi S, Perfumo F, Edefonti A, Zacchello G, Andreetta B, Pela I, Penza R, Piaggio G, Picca M, Cantaluppi A (1993) Analysis of complications in a chronic peritoneal dialysis pediatric patient population. Perit Dial Int 13: S257-S259
Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA (1992) Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 42: 967–974
Owen JE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ (1992) Randomized study of peritonitis with conventional versus o-set techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 12: 216–220
Oreopoulos OG, Robson M, Izatt S (1978) A simple and safe technique for continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 24: 484–489
Keane WF, Everett ED, Golper TA, Gokal R, Halstenson C, Kawaguchi Y, Riella M, Vas S, Verbrugh HA (1993) Peritoneal dialysis-related peritonitis treatment recommendations 1993 update. Perit Dial Int 13: 14–28
Dixon WJ, Massey FJ (1983) Introduction to statistical analysis. McGraw Hill, New York
Neiberger R, Aboushaar MH, Tawan M, Fennell R, Iravani A, Richard G (1991) Peritonitis in children on chronic peritoneal dialysis: analysis at 10 years. Adv Perit Dial 7: 272–274
Verrina E, Edefonti A, Bassi S, Perfumo F, Zacchello G, Andreetta B, Caringella D, Lavoratti G, Picca M, Rinaldi S, Viglino G, Cantaluppi A (1992) Peritonitis in children undergoing chronic peritoneal dialysis (CPD): data from the Italian Registry of Pediatric CPD. Adv Perit Dial 8: 419–422
Howard RL, Millspaugh J, Teitelbaum I (1990) Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis. Am J Kidney Dis 16: 469–472
Levy N, Balfe JW, Geary D, Fryer-Keene SP (1990) Factors predisposing and contributing to peritonitis during chronic peritoneal dialysis in children: a ten-year experience. Perit Dial Int 10: 263–269
Keane WF, Comty CM, Verbrugh HA, Peterson DK (1984) Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 25: 539–543
Holmes C, Lewis S (1991) Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. 2. Humoral defenses. Perit Dial Int 11: 112–117
Lamperi S, Carozzi S (1986) Defective opsonic activity of peritoneal effluent during continuous ambulatory peritoneal dialysis (CAPD): importance and prevention. Perit Dial Bull 6: 87–92
De Vecchi A, Castelnovo C, Failla N, Scalamogna A (1990) Clinical significance of peritoneal dialysate IgG levels in CAPD patients. Adv Perit Dial 6: 98–101
Holmes CJ (1993) Peritoneal immune defense in CAPD: clinical relevance and practical implications. Perit Dial Int 2: S-278–S-281
Holmes CJ (1990) CAPD-associated peritonitis: an immunological perspective on causes and interventions. Contrib Nephrol 86: 73–88
Schroder CH, Bakkeren JAJM, Weemaes CMR, Monnens LAH (1989) IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 261–266
Holmes CJ (1994) Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int 48: S-58–S-70
Peraino B (1990) A review ofStaphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients. Am J Kidney Dis 16: 89–95
Piraino B, Bernardini J, Holley JL, Perlmutter JA (1993) A comparison of peritoneal dialysis-related infections in short- and long-term peritoneal dialysis patients. Perit Dial Int 13: 194–197
Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Moncalian J, Fernandez-Rivera C, Cao M, Valdes F (1992) Treatment ofStaphylococcus aureus nasal carriers in CAPD with mupirocin. Adv Perit Dial 8: 242–245
Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ (1986)Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 315: 91–96
Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M, Oxton L, Roecker EB, Engeseth S (1991) Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 18: 225–231
Poole-Warren LA, Hallett MD, Hone PW, Burden SH, Farrell PC (1991) Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial. Clin Nephrol 35: 198–206
Fattom A, Schneerson R, Watson DC, Karakawa WE, Fitzgerald D, Pastan I, Li X, Shiloach J, Bryla DA, Robins JB (1993) Laboratory and clinical evaluation of conjugate vaccines composed ofStaphylococcus aureus type 5 and type 8 capsular polysaccharides bound toPseudomonas aeruginosa recombinant exoprotein A. Infect Immun 61: 1023–1032
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuizon, B., Melocoton, T.L., Holloway, M. et al. Infectious and catheter-related complications in pediatric patients treated with peritoneal dialysis at a single institution. Pediatr Nephrol 9 (Suppl 1), S12–S17 (1995). https://doi.org/10.1007/BF00867677
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00867677